When care is complex, access should be simple.

Eliminating the friction between care and supply for chronic wound care providers.

Meet the AMA team.

Amniotic Membrane Allografts

Explore the differences between amniotic layers.

Chorion Layer

The chorion membrane interacts directly with the maternal tissue, allowing for nutrient movement between the maternal tissue and fetal tissue. The chorion has three main layers of a reticular layer, a basement membrane, and trophoblast. The chorion layer is roughly five times thicker than the amnion membrane at approximately 0.2 mm thick. Biomolecules found in the chorion are collagens I and III–VI, proteoglycans, fibronectin, ANG, FGF, VEGF, and HGH. Studies have shown that the chorion membrane also has similar beneficial characteristics as that of the amnion, displaying anti-inflammatory and antimicrobial characteristics. 

The intermediate layer is located between the amnion and chorion membranes. It functions as an interface between the fetal facing amnion and the maternal facing chorion membranes. Some biomolecules found in the intermediate layer are collagen I, III, and IV, proteoglycans, and glycoproteins, such as hyaluronic acid and heparan sulfate. The intermediate layer has a physical structure that is spongy-like and acellular.

Amnion is the innermost placental membrane tissue. Amnion is composed of epithelium, basement membrane, compact layer, and fibroblast. In the womb the amnion functions as a permeable barrier that allows for transport of nutrients between the maternal tissue and fetal tissue. The amnion membrane is thin, roughly 0.5mm thick, which is mostly the result of compact layer’s thickness. The amnion membrane comprises biomolecules such as collagens I, III, and IV–VI, fibronectin, FGF, VEGF, and EGF. Studies have shown that the amnion membrane has beneficial characteristics of being anti-inflammatory, antimicrobial, and immunologically privileged.

Rendered images shown are for illustrative purposes only and do not reflect actual product structure or clinical outcomes.

Meet the Founder

For Roger,
this is personal.

Timing. Consistency. Trust.

We bring together professionals passionate about ensuring providers have what they need, when they need it.

We understand distribution complexities.

Every detail matters.

 

From documentation and Q-codes to product traceability and logistics, our staff is trained in the regulatory and operational requirements that keep ordering, documentation, and delivery smooth and dependable. We stay informed on FDA and CMS updates so providers can rely on accurate, current information.

Want to read more?

From amniotic grafts to other biologics, we connect providers to a diverse selection of advanced wound care products.

With one agreement you’ll have access to a broad portfolio sourced from FDA-registered manufacturers. Our range allows providers to choose products appropriate for their specific care settings under CMS-defined guidelines.

Want to read more?

Rendered images shown are for illustrative purposes only and do not reflect actual product structure or clinical outcomes.

We believe great service is about consistency and clarity.

From your first order to final delivery, our team is available to answer questions, coordinate logistics, and ensure a smooth process. We prioritize responsiveness, reliability, and accurate communication because behind every shipment is a provider (and a patient) who is depending on it.

Want to read more?

Roger Chasteen on the phone.

Compliance isn’t a checkbox. It’s part of how we work.

Every process, from sourcing to fulfillment, is built on adherence to federal and industry requirements. We follow industry standards in all distribution practices and ensure our partners have access to transparent, accurate documentation.

Want to read more?

Subscribe to our email list and stay connected.